Victoza

RSS

liraglutide

Authorised
This medicine is authorised for use in the European Union.

Overview

Victoza is a medicine used in addition to diet and exercise in adults and children from 10 years of age who have type 2 diabetes.

Victoza is used:

  • on its own when use of metformin (another medicine for type 2 diabetes) is not recommended;
  • as an ‘add-on’ to other diabetes medicines.

Victoza contains the active substance liraglutide.

This EPAR was last updated on 29/04/2021

Authorisation details

Product details
Name
Victoza
Agency product number
EMEA/H/C/001026
Active substance
liraglutide
International non-proprietary name (INN) or common name
liraglutide
Therapeutic area (MeSH)
Diabetes Mellitus, Type 2
Anatomical therapeutic chemical (ATC) code
A10BJ02
Publication details
Marketing-authorisation holder
Novo Nordisk A/S
Revision
22
Date of issue of marketing authorisation valid throughout the European Union
30/06/2009
Contact address

Novo Allé
DK-2880 Bagsvaerd
Denmark

Product information

24/09/2020 Victoza - EMEA/H/C/001026 - PSUSA/00001892/201912

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

Victoza is indicated for the treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
  • in addition to other medicinal products for the treatment of diabetes.

For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied.

Assessment history

Changes since initial authorisation of medicine

Related content

How useful was this page?

Add your rating
Average
2 ratings
1 rating
1 rating
1 rating